2011 Lamborghini Gallardo Super Trofeo
An original Lamborghini Gallardo, built in 2011.
This vehicle has 4WD with 570 bhp and Paddle Shift at the steering wheel. Fuel tank capacity of 120 liters. Öhlins shock absorbers, Brembo brakes with ABS. Weight: 1,290 kg. Engine, transmission and other parts are Lamborghini originals. Low maintenance costs. The vehicle is in perfect condition, the engine and transmission have just over 2,000 km on them. Radio system and several spare parts. Race ready.
- Certificate and documents: ASI (Italian Historical Car Club)
- Racing hours: 30
- Color: black
- Engine: 5,204 cc V10 - 570 cv
Valued at €300,000.
Terms and conditions:
- Delivery of the vehicle is at the winner's expense. Shipping costs will be calculated at the close of the auction on the basis of the shipping address
- Delivery of the vehicle must be coordinated within 30 days of the auction close
- It is a race car, and therefore non-registered. The winner will not receive any documents other than the vehicle invoice
- Winner is responsible for all registration and transfer of ownership fees
The “Center for Autoimmune Liver Diseases” is a tertiary referral center and one of the largest center for autoimmune liver disease internationally with a very active program of basic and clinical research in autoimmune liver diseases (ALD) based on the availability of a wealth of clinical material. Currently more than 1000 Italian patients with ALD, such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), and their dreadful complication cholangiocarcinoma are followed at the “Center”. The “Center” was recently accreditated as one of the Italian Collaborative Centers of the European Reference Network on the rare liver diseases such as ALD. Is part of the Division of Gastroenterology of the School of Medicine at San Gerardo Hospital in Monza, University of Milan Bicocca, and was created to coordinate the activities of prevention, diagnosis and treatment of these diseases through a multidisciplinary team consisting of internists, hepatologists, gastroenterologists, clinical immunologists, radiologists, pathologists and surgeons. The goal is to provide the patient with a full course of treatment, diagnosis and therapy.The team is committed to understand the etiopathogenetic aspects of ALD, with particular attention for the development of novel diagnostic and prognostic markers, understanding their genetic and epigenetic architecture, and development of novel therapies. Finally, an epidemiological observatory was open to monitor the prevalence and incidence of ALD in Italy and the rest of the world.